Associate Professor Peter O'Brien
Peter O'Brien is a radiation oncologist with more than 20 years' experience in the treatment of cancer and research into improving treatment. He has a particular interest in the management of breast and gynaecological cancer, sarcoma and lymphoma and is actively involved with multi-disciplinary care for all of these tumour types.
Peter has authored more than 60 scientific peer reviewed papers and book chapters and is a reviewer for a number of international journals. He collaborates in current clinical trials and for many years was the Scientific Advisor for the Trans Tasman Radiation Oncology Group receiving the "Outstanding Contribution Award" for his efforts in research. More recently he was appointed to the local therapies group of the Australian and New Zealand Breast Cancer Trials Group and has been an invited speaker at a number of national and international scientific forums.
Training, teaching and mentoring have formed an important part of his professional role and he has been an examiner for the Faculty of Radiation Oncology (RANZCR) and a Board Member. Quality Assurance in daily practice and clinical trials has become an increasing area of interest particularly with increasing complexity in radiation oncology.
Dr Anne Capp
Dr Anne Capp is a Radiation Oncologist, with a staff specialist appointment at Calvary Mater Newcastle and a conjoint senior lecturer position with the Faculty of Health and Medicine, University of Newcastle. She is a clinician with subspeciality interests in urological, gastro-intestinal, breast and lymphoma malignancies; and has actively recruited patients from these areas onto a number of multi-centre clinical trials. She is currently Radiotherapy Lead of the Gynae-oncology/Brachytherapy clinical stream.
Previous posts include Director of the Department of Radiation Oncology, Calvary Mater Newcastle from 2010 to 2012, staff specialist at Illawarra Cancer Care Centre, Wollongong Hospital from 1997 to 2006, and Clinical Research Fellow, Royal Marsden Hospital, United Kingdom from 1994 to 1997. She is actively involved in clinical trials both as a recruiter of patients and through the TROG group as quality assurance reviewer for several trials. She completed her undergraduate training at the University of Tasmania in 1987. She undertook her radiation oncology training at St Vincents Hospital and St George Hospital, Sydney, and has both Australian and United Kingdom fellowships. She has also completed a Masters of Medicine in Clinical Epidemiology through the University of Sydney.
Dr Mike Fay
MBChB, FRACP, FRANZCR
Genesis CancerCare Newcastle
Dr Fay is a dual trained Medical and Radiation Oncologist who specialises in neuro-oncology, stereotactic radiosurgery, thoracic and gastrointestinal oncology.
He completed his undergraduate degree Medicine and Surgery at University of Otago 1993 and is currently completing his PhD on integrating advanced imagery into brain tumour treatment.
Dr Fay has carried out extensive research with a particular focus on brain tumours and the development of new imaging and treatment techniques and is the principal investigator in a number of international cancer trials and collaborations with Canada, the UK and Germany. His research spans across several modalities including PET imagery, MRI imaging and developing multiplexed neuro-imaging techniques. As well as securing over $4.5m in research funding over the last ten years, he is a lead researcher in an NCIC trial into brain tumour treatment in elderly patients. A current research project centres on developing a new PET tracer for use in brain tumours.
Dr Fay has two published book chapters has almost 50 publications on both lung and neuro oncology and alongside his commitment to research he is a senior lecturer at the University of Queensland and a conjoint senior lecturer at the University of Newcastle. He is also an active member of ASCO, ASTRO and COGNO and on the editorial board of The Journal of Translational Lung Cancer Research.
Assoc Prof. Jarad Martin
BSc MBChB DMed (Research), FRANZCR GAustMS
A/Prof Jarad Martin is a radiation oncologist with strong research interests. He subspecialises in the multidisciplinary management of gastrointestinal tumours (including tumours of the oesophagus, stomach, pancreas, colon, rectum and anal canal) as well as genitourinary malignancies (including prostate and bladder cancers). A more recent interest is the use of low dose radiotherapy for conditions such as plantar fasciitis and Dupuytren’s contracture.
Jarad attends and contributes to the Newcastle multidisciplinary meetings discussing patients with all of these types of cancer, and has a leading role in helping organise specialist education events in the Hunter region. His technical knowledge is well recognized in areas including image guided radiotherapy (IMRT), image guided radiotherapy (IGRT) and stereotactic radiotherapy (SBRT). Having worked in Victoria, Queensland and Canada prior to commencing practice in Newcastle, he is able to bring a broad perspective to his management of people with cancer.
Dr Katherine Neville
Dr Neville completed her specialist training at the Calvary Mater Hospital, Royal North Shore Hospital, and Liverpool Hospital before being becoming a Fellow of the Royal Australian and New Zealand College of Radiologists (Faculty of Radiation Oncology) in 2016.
She has received training in the management of all tumour types, however, has a special interest in the treatment of head and neck cancers, breast cancer, lung cancer, benign diseases and the use of radiation for symptom control in advanced cancer.
As well as her clinical interests, Dr Neville has completed research projects in the use of radiotherapy for Mantle Cell Lymphoma, Non-Small Lung Cancer, and Breast Cancer.
She is currently finishing her Masters of Clinical Epidemiology through the University of Newcastle (due completion mid-2018).
Dr Philippa Ell
Dr Ell completed medical school at University of Notre Dame in Western Australia in 2009. Since that time, she has also completed a Certificate in Clinical Epidemiology at University of Sydney.
She did her specialist training in NSW and during that time spent time at Calvary Mater, Newcastle, St George Public Hospital Kogarah and Prince of Wales Public Hospital in Randwick.
She completed a clinical/research fellowship at St Vincent’s Hospital, NSW, focusing on head and neck and CNS malignancies.
Dr Ell has an interest in medical education and is Conjoint Lecturer, University of New South Wales and Conjoint Fellow, University of Newcastle. She regularly presents for HETI’s “Basic Sciences in Oncology” course, presenting at RANZCR’s NSW Radiation Oncology trainee teaching days and lectures to medical students.
Having recently returned to live in Newcastle from Sydney, where she worked with GenesisCare at St Vincent’s, Dr Ell is available to take referrals and looks forward to caring for the region's patients.
Dr Matt Mason
Matt is a Radiation Oncologist with over 10 years of experience in Oncology. After graduating from Nottingham University, he became a Clinical Oncologist, training at St James’s University Hospital in Leeds, UK. With interests in technical radiotherapy he completed a two year clinical fellowship at Princess Margaret Cancer Centre, Toronto, Canada. This experience focused on the management of head and neck malignancies, CNS tumours and spinal stereotactic radiotherapy.
Matt worked as a Locum Consultant at St James University Hospital. Having moved to Australia and achieving specialist recognition, Matt worked as a Staff Specialist in Radiation Oncology at the Calvary Mater in Newcastle. Head and Neck cancer management has remained a strong interest of Matt’s. He has also developed interests in the management of Breast and Skin Cancers.
Matt takes an active role in research and has several publications. He has a Conjoint appointment as Lecturer, with the University of Newcastle School of Medicine and Public Health and enjoys providing clinical teaching for patients, students and trainees.
- Patient focused research
- Clinical trials
Matt is interested in Patient Reported Outcomes and how these might guide patient care. He also is interested in technical radiotherapy advances to improve cancer control and reduce patient side effects.